Combination therapy for treatment of ovarian cancer

• 收藏
• 分享

专利权人:

Synta Pharmaceuticals Corp

发明人:

Proia, David

申请号：

AU2017227534

公开号：

AU2017227534A1

申请日:

2017.02.28

申请国别(地区):

AU

年份:

2018

代理人:

摘要：

This invention relates to methods of treating a patient with ovarian cancer having deficiencies in homologous recombination (HR) comprising administering to the patient (i) an effective amount of ganetespib, or a pharmaceutically acceptable salt thereof； and (ii) an effective amount of a DNA-damaging or repair-inhibiting agent.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/